For early-stage pharma and biotech companies, comprehensive intellectual property (IP) strategies do more than protect innovation. They set the stage for your company's long-term success – helping raise funds, attract partners and expand into new markets.
Our Vancouver IP Group has created a three-part video series to provide early-stage life sciences companies with the resources they need to ensure their IP assets are protected in a highly competitive market.
Mark Wilke, partner and patent agent, gives an introduction into the various IP assets – patents, industrial designs/design patents, trademarks, copyrights and trade secrets – that are fundamental for life sciences companies.
Five IP considerations for startups
Sonia Ziesche, principal and chair of the Vancouver Life Sciences Group, and Edith Penty-Geraets, chartered (UK) patent attorney and European patent attorney, review a variety of factors that every startup company should take into account when creating an IP strategy. Topics include:
- IP housekeeping
- IP and employees
- Cost forecasting
- Patent application filing
- Filing strategy
Strategies on how to build an IP portfolio for growth
Partner Lisa Thorne and associate Jayde Wood share practical tips for creating an IP portfolio that will distinguish life sciences companies apart from their competitors in the industry. This video will help companies recognize the different types of IP protection, as well as how to align their IP strategy to advance their business goals.
Are you ready to take your IP strategy to the next level? We can help.
After watching the videos, you will have questions about obtaining, protecting and maximizing IP assets. Let us give you those answers. Contact one of our IP practitioners by filling out the form below to schedule a complimentary 30-minute discussion, where we will learn about your company's requirements and understand how we can help develop the right IP strategy for your business.